Apellis Announces Investor Conference Call to Discuss Phase 3 PEGASUS Data to be Presented at the 25th Annual Congress of the European Hematology Association (EHA)

NEXT STORY
Lantern Pharma Announces Pricing of Initial Public Offering
PREV STORY
WidePoint to Showcase TM2 Solutions at ATARC’s The Role of Emerging Technology in the Federal Emergency Response Summit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis to highlight extensive long-term safety and efficacy data of Aimovig® across the spectrum of migraine at AAN

author_avatar
NASDAQ Market News

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Enrollment continues in Phase 3 GBM brain cancer trialKey European patent validated covering oral ...

author_avatar
NASDAQ Market News

Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies

INDIANAPOLIS and BERKLEY, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Eli Lilly and Company ...

author_avatar
NASDAQ Market News